AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.34
−0.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 13.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.84x
- Price / sales
- 12.39x
- Price / cash flow
- -14.77x
Enterprise value
- Enterprise value
- $630.7M
- EV / sales
- 11.66x
- EV / EBITDA
- -10.29x
- EV / EBIT
- -11.96x
- Market cap
- $670.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026